Published : 12 Jul 2024
Aagami’ s objective for BIO-Europe® 2024 is to meet companies seeking strategic partnerships/M&A for their assets and technologies.
Aagami will also be representing several partnering opportunities of its clients across M&A, licensing, co-development, alliance, JV, and investment business models.
Vice-President Godwyn Francis will attend the event representing Aagami and its clients. He would be having 20+ one-on-one strategic meetings with Pharma, Biotech and MEDTECH decision makers.
If you would like to meet us during the conference, please use the BIO-Europe® 2024 partnering system or contact Godwyn at godwyn@aagami.com.